The conference will be online over several days including mini-sessions and 2 full days of lectures in 2-3 hour segments. It’s sure to be even bigger and better than last year’s conference that sold out!
This is the third annual conference for the American Society of Ketamine Physicians, Psychotherapists and Practitioners. A conference involving multi-disciplinary speakers discussing ketamine use for mood disorders, psychotherapy and pain conditions. Please join us for this educational conference and extraordinary networking experience.
Megan Oxley, MD
Michigan Progressive Health
Vice President, American Society of Ketamine Physicians, Psychotherapists & Practitioners, Founder and Medical Director of Michigan Progressive Health.
Sandhya Prashad, MD
Houston Ketamine Therapeutics
President, American Society of Ketamine Physicians, Psychotherapists & Practitioners, Founder and Medical Director of Houston Ketamine Therapeutics and Houston TMS Therapeutics.
Rupert McShane, MD
Associate Professor, Department of Psychiatry, Oxfordshire ECT
Dr. Rupert McShane is interested in treatment-resistant depression and dementia. Clinically, he leads the Oxfordshire ECT and ketamine services and run a memory clinic.
Jason Wallach, PhD
Instructor, University of the Sciences
Dr. Jason Wallach teaches courses in Laboratory Biomethods, Pharmacology and Toxicology Laboratory Techniques, Psychopharmacology, Pathology, Simulated Physiology Labs and Toxicology.
Sagar V. Parikh, MD, FRCPC
University of Michigan Depression Center
John F. Greden Professor of Depression and Clinical Neuroscience Professor of Psychiatry Associate Director, University of Michigan Depression Center.
Ravi Das, BSC, MSC, PhD
Associate Professor, University College London
Dr. Ravi Das is a researching psychopharmacologist based in the sub-department of Clinical, Educational and Health Psychology and lecturer in Research Methods and Statistics on the DEdPsy and DECPsy courses.
Will Van Derveer, MD
Integrative Psychiatric Healing Center. Will Van Derveer, MD is a psychiatrist and psychotherapist with several years of experience participating in indigenous shamanic medicine ceremonies abroad.
Elias Dakwar, MD
Principal Investigator, New York State Psychiatric Institute
He is currently principal investigator on several studies evaluating the effects of various medications on opioid, cannabis, or cocaine use disorders in both clinical and laboratory settings at the New York State Psychiatric Institute. Dr. Dakwar was recently awarded a K23 award from NIDA to continue his clinical and laboratory investigations of ketamine infusions combined with mindfulness training to treat cocaine use disorders
Assistant Psychologist, Centre for Psychedelic Research
Ashleigh Murphy-Beiner is an assistant psychologist at the Centre for Psychedelic Research at the Imperial College in London, who examines the therapeutic potential of ayahuasca for treating depression and anxiety and the mechanisms of action involved in ayahuasca’s therapeutic effects.
Let's get in touch
Give us a call or drop by anytime, we endeavour to answer all enquiries within 24 hours on business days.